Breaking News
January 19, 2019 - New Leash on Life? Staying Slim Keeps Pooches Happy, Healthy
January 19, 2019 - Men and women remember pain differently
January 19, 2019 - Rising air pollution linked with increased ER visits for breathing problems
January 19, 2019 - Study uses local data to model food consumption patterns among Seattle residents
January 19, 2019 - The brain’s cerebellum plays role in controlling reward and social behaviors, study shows
January 19, 2019 - Relationship between nurse work environment and patient safety
January 19, 2019 - Pioneering surgery restores movement to children paralyzed by acute flaccid myelitis
January 19, 2019 - Genetic variants linked with risk tolerance and risky behaviors
January 19, 2019 - New research provides better understanding of our early human ancestors
January 19, 2019 - First-ever tailored reporting guidance to improve patient care and outcomes
January 19, 2019 - 4.6 percent of Massachusetts residents have opioid use disorder
January 19, 2019 - New study suggests vital exhaustion as risk factor for dementia
January 19, 2019 - New antibiotic discovery heralds breakthrough in the fight against drug-resistant bacteria
January 19, 2019 - Ural Federal University scientists synthesize a group of multi-purpose fluorophores
January 19, 2019 - Researchers identify new therapeutic target in the fight against chronic liver diseases
January 19, 2019 - Preparation, characterization of Soyasapogenol B loaded onto functionalized MWCNTs
January 19, 2019 - FDA Approves Ontruzant (trastuzumab-dttb), a Biosimilar to Herceptin
January 19, 2019 - Tobacco use linked with higher use of opioids and sedatives
January 19, 2019 - Study delves deeper into developmental dyslexia
January 19, 2019 - Anti-vaccination movement one of the top health threats in 2019 says WHO
January 19, 2019 - Newly developed risk score more effective at identifying type 1 diabetes
January 19, 2019 - Highly effective protocol to prepare cannabis samples for THC/CBD analysis
January 19, 2019 - Prinston Pharmaceutical Inc. Issues Voluntary Nationwide Recall of Irbesartan and Irbesartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodiethylamine (NDEA) in the Products
January 19, 2019 - How does solid stress from brain tumors cause neuronal loss, neurologic dysfunction?
January 19, 2019 - $14.7 million partnership to supercharge vaccine development
January 19, 2019 - Ian Fotheringham receives Charles Tennant Memorial Lecture award
January 19, 2019 - Brain vital signs detect neurophysiological impairments in players with concussions
January 19, 2019 - Lack of job and poor housing conditions increased likelihood of people attending A&E
January 19, 2019 - Novel targeted drug delivery system improves conventional cancer treatments
January 19, 2019 - Rutgers study finds gene responsible for spread of prostate cancer
January 19, 2019 - Complications Higher Than Expected for Invasive Lung Tests
January 19, 2019 - 3-D printed implant promotes nerve cell growth to treat spinal cord injury
January 19, 2019 - Automated texts lead to improved outcomes after total knee or hip replacement surgery
January 19, 2019 - Poor cardiorespiratory fitness could increase risk of future heart attack, finds new study
January 19, 2019 - Drinking soft drinks while exercising in hot weather may increase risk of kidney disease
January 19, 2019 - Formlabs 3D prints anatomical models
January 19, 2019 - Heart-Healthy Living Also Wards Off Type 2 Diabetes
January 19, 2019 - Teaching Kids to Be Smart About Social Media (for Parents)
January 19, 2019 - Metabolite produced by gut microbiota from pomegranates reduces inflammatory bowel disease
January 19, 2019 - Researchers examine how spray from showers and toilets expose us to disease causing bacteria
January 19, 2019 - Behavioral experiments confirm that additional neurons improve brain function
January 19, 2019 - New study compares performance of real-time infectious disease forecasting models
January 19, 2019 - Obesity can be risk factor for developing renal cell carcinoma, confirms study
January 19, 2019 - New regulation designs on cigarette packs direct smokers’ attention to health warnings
January 19, 2019 - QIAGEN receives first companion diagnostic approval in Japan
January 19, 2019 - Study explores role of Dunning-Kruger effect in anti-vaccine attitudes
January 19, 2019 - Newly identified subset of immune cells may be key to fighting chronic inflammation
January 19, 2019 - New immune response regulators discovered
January 18, 2019 - Poor blood oxygenation during sleep predicts chance of heart-related death
January 18, 2019 - First international consensus on the diagnosis and management of fibromuscular dysplasia
January 18, 2019 - Rapid resistance gene sequencing technology can hasten identification of antibiotic-resistant bacteria
January 18, 2019 - Researchers develop artificial enzymatic pathway for synthesizing isoprenoids in E. coli
January 18, 2019 - Scientists advise caution in immunotherapy research
January 18, 2019 - How children across the world develop language
January 18, 2019 - Columbia Medical Student Receives McDonogh Scholarship
January 18, 2019 - Secretive ‘Rebate Trap’ Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
January 18, 2019 - Plant based diet could be the best option for the planet says commission
January 18, 2019 - New conservation practice could reduce nitrogen from agricultural drainage, study shows
January 18, 2019 - UIC researchers receive $1.7 million NCI grant to study Southeast Asian fruit
January 18, 2019 - New study determines the fate of DNA derived from genetically modified food
January 18, 2019 - Scientists develop new gene therapy that prevents axon destruction in mice
January 18, 2019 - Study finds critically low HPV vaccination rates among younger adolescents in the U.S.
January 18, 2019 - Brain cells involved in memory play key role in reducing future eating behavior
January 18, 2019 - Risk for Conversion of MS Varies With Different Therapies
January 18, 2019 - Investigational cream may help patients with inflammatory skin disease
January 18, 2019 - Medical school news office receives six writing awards | News Center
January 18, 2019 - County By County, Researchers Link Opioid Deaths To Drugmakers’ Marketing
January 18, 2019 - Research reveals risk for developing more than one mental health disorder
January 18, 2019 - Scientists discover a dramatic pattern of bone growth in female mice
January 18, 2019 - Study finds link between lengthy periods of undisturbed maternal sleep and stillbirths
January 18, 2019 - New nuclear medicine method could improve detection of primary and metastatic melanoma
January 18, 2019 - Combination therapy shows high efficacy in treating people with leishmaniasis and HIV
January 18, 2019 - Health Tip: Don’t Ignore Changes in Skin Color
January 18, 2019 - Dietary Recommendations for Healthy Children
January 18, 2019 - Eliminating the latent reservoir of HIV
January 18, 2019 - Pain From The Government Shutdown Spreads. This Time It’s Food Stamps
January 18, 2019 - Newly discovered regulatory mechanism helps control fat metabolism
January 18, 2019 - New rapid blood tests could speed up TB diagnosis, save the NHS money
January 18, 2019 - Researchers develop intelligent system for ‘tuning’ powered prosthetic knees
January 18, 2019 - Monoclonal antibody pembrolizumab prolongs survival in patients with squamous cell carcinoma
Research points to new target for treating periodontitis

Research points to new target for treating periodontitis

image_pdfDownload PDFimage_print

T cells help fight off infection, but they can go overboard. A new study led by researchers at the University of Pennsylvania School of Dental Medicine and the National Institutes of Health (NIH) shows that a subset of T cells contributes to the problematic inflammation and bone loss that is associated with periodontitis, a severe form of gum disease.

The research, conducted with the help of animal models and a group of human patients with a rare genetic mutation, point to a new target for treating periodontitis, as well as other diseases involving the inappropriate response of this group of T cells, known as Th17 cells. These include autoimmune conditions such as rheumatoid arthritis and multiple sclerosis. The work appears in Science Translational Medicine.

“I think this work leaves no doubt that these cells are important mediators of periodontitis,” says George Hajishengallis, the Thomas W. Evans Centennial Professor in the Department of Microbiology at Penn Dental Medicine. “The translational aspect of our studies is pinpointing a new approach to blocking the tissue destruction we see in periodontitis, by inhibiting Th17 development.”

Hajishengallis collaborated on the work with Niki M. Moutsopoulos of the NIH’s National Institute for Dental and Craniofacial Research, with whom he has made previous insights into the molecular drivers of periodontitis.

T cells are broadly considered to fall into two categories: helper T cells, which aid in orchestrating the immune system’s response to threats, and cytotoxic T cells, which take a lead role in carrying out an attack. Until about 13 years ago, helper cells were further divided into two groups: Th1 or Th2 cells. Then a new subset, Th17 cells, was identified, and researchers quickly realized Th17 cells played a role in certain human diseases. By 2008, Hajishengallis and other researchers began to suspect that these cells may be implicated in periodontitis. More recent studies have found that people with chronic periodontitis have an unusually high number of Th17 cells in their gum tissue, but these investigations hadn’t uncovered the particular role of these cells in the condition or whether they were required for the development of periodontitis.

In the current work, the researchers looked at gum tissue from patients with chronic periodontitis and confirmed that they had higher numbers of Th17 cells compared to healthy controls, with the numbers correlating with the severity of disease. In parallel, they observed that mice in which periodontitis was induced, Th17 cell numbers, along with the IL-17 signaling molecule which they produce, increased with the onset of gum disease. This increase in Th17 cell numbers, the researchers found, was the result of local proliferation rather than recruitment from nearby lymph nodes.

To interrogate possible triggers of the local expansion of Th17 cells, the team decided to see how changes in the community of microbes in the gum tissue, the gingival microbiome, affected the accumulation of Th17 cells. In the mouse model of disease, animals were treated with broad- or narrow-spectrum antibiotics. Only those antibiotics which lowered the numbers of Th17 cells were capable of suppressing the disease, again implicating these cells in disease.

To definitively link the cells to the condition, however, the researchers took advantage of a mouse model missing a key protein required for Th17 cell development, as well as a population of human patients with a mutation in the corresponding gene, Stat3, who are monitored at the NIH. In both cases, they found that the Stat3 mutation, which dramatically cut the number of Th17 cells present in the gum tissue, also protected against the bone loss seen in chronic periodontitis. While people with this Stat3 mutation have other problems, gum disease is not one of them.

“Here we have a unique patient population with the same defect we checked in the mice, and they are similarly not susceptible to the same disease,” Hajishengallis says. “This type of rigorous evidence is not easy to come by in medical science.”

Though antibiotics could serve to protect against the disease, the side effects of taking such drugs, which can kill both beneficial and disease-causing microbes throughout the body, are too significant to recommend the treatment for broad use. But employing a small-molecule that inhibits Th17 cell development gave the researchers a similar effect, reducing Th17 cell accumulation and associated periodontal bone loss in mice.

“There is no antibiotic that is that targeted, that specific,” Hajishengallis says. Such an inhibitor offers promise as a periodontal therapy and perhaps as a target for treating other diseases in which Th17 play a destructive role.

Source:

https://penntoday.upenn.edu/news/drivers-inflammation-provide-valuable-targets-new-gum-disease-therapies

Tagged with:

About author

Related Articles